Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02749 (
beta2-glycoprotein I
)
836
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
apolipoprotein H
(
APO
H) polymorphism was analyzed in the Negroid population from the Ivory Coast using polyacrylamide gel isoelectric focusing, followed by immunoblotting. The gene frequencies of alleles
APO
H*1,
APO
H*2,
APO
H*3 and
APO
H*4 were calculated to be 0.012, 0.921, 0.047, and 0.020, respectively. The assumption that
APO
H*4 represents a Negroid marker allele is supported by this population study.
...
PMID:Genetic polymorphism of apolipoprotein H (beta 2-glycoprotein I) in African blacks from the Ivory Coast. 128 82
Apolipoprotein H
(
APO
H), also known as
beta 2-glycoprotein I
, has been identified as a protein component of the major lipoprotein density fractions in human plasma. Recently, genetically determined structural polymorphism in white and black populations has been documented for this apolipoprotein. There are three common alleles in whites and blacks and a fourth allele found mainly in blacks. Family data confirm the autosomal codominant pattern of inheritance for the
APO
H structural gene. Little is known about the function of
APO
H, but it has demonstrated both lipid and platelet involvement. In this study we investigate the effect of
APO
H phenotypes on quantitative lipid measures in a group of 443 white women being followed through menopause for changes in cardiovascular risk. At baseline all women were premenopausal. None of the
APO
H phenotypes showed a statistically significant effect on lipid measures in this population.
...
PMID:Phenotypic effects of apolipoprotein structural variation on lipid profiles. I. APO H and quantitative lipid measures in the healthy women study. 272 26
Apolipoprotein H
(
APO
H) has recently been identified as a structural component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). Although the precise metabolic function of
APO
H in lipid metabolism is not certain, it has been suggested that
APO
H may be involved in triglyceride (TG) metabolism. In addition to the previously described quantitative polymorphism, we have recently detected a common qualitative polymorphism at the
APO
H structural locus. To test the role of
APO
H genetic variation in determining lipoprotein and lipid levels, we have estimated the allelic effects of
APO
H variation on TG, VLDL, LDL, HDL, HDL3, and total cholesterol on 356 Nigerian blacks (189 males, 167 females). While no significant effect of phenotype was observed on lipoprotein levels, the effect of interaction between phenotype and gender was significant. Therefore, data on males and females were analyzed separately using analysis of variance after adjusting for age and body mass index. Logarithmic transformation of pertinent variables was done to bring the distribution of the variables closer to normality. A statistically significant effect of phenotype was observed on triglyceride levels in females only (P less than 0.05). Further analysis of this phenotypic effect revealed that it is due to the impact of the
APO
H*3 allele, which raises triglycerides by 9.92 mg/dl as compared to the common allele,
APO
H*2. These findings are in accordance with the postulated role of
APO
H in triglyceride metabolism. On the basis of its sex-specific effect, we propose a hypothesis that may explain the combined influence of the quantitative and qualitative polymorphisms at the
APO
H locus on triglyceride levels in females.
...
PMID:Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations. 272 86
Human
beta 2-glycoprotein I
has recently been identified as a component of several human plasma lipoprotein fractions and therefore termed as
apolipoprotein H
. Its metabolic function in lipid metabolism is not known with certainty, though it may be involved in very-low-density-lipoprotein metabolism. Previously, inherited quantitative variation in
beta 2-glycoprotein I
has been suggested in man. In this investigation, we document the evidence of genetically determined structural polymorphism of
apolipoprotein H
or
beta 2-glycoprotein I
by using thin-layer polyacrylamide isoelectric focusing gels followed by immunological identification by double antibody staining. The
apolipoprotein H
structural locus is characterized by the occurrence of three common alleles in U.S. whites and blacks. The frequency distributions of the three alleles designated
APO
H1,
APO
H2, and
APO
H3 are .059, .882, and .059 in whites and .017, .902, and .068 in blacks, respectively. In addition, the gene product of a fourth allele,
APO
H4, has been observed at polymorphic frequency in black individuals and may represent a black marker variant. Family data confirm the hypothesis of four alleles at a single
APO
H gene locus with an autosomal codominant pattern of inheritance.
...
PMID:Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I). 334 13